Ad is loading...
FMDRX
Price
$32.79
Change
+$0.14 (+0.43%)
Updated
Nov 22 closing price
LZFOX
Price
$10.01
Change
+$0.11 (+1.11%)
Updated
Nov 22 closing price
Ad is loading...

FMDRX vs LZFOX

Header iconFMDRX vs LZFOX Comparison
Open Charts FMDRX vs LZFOXBanner chart's image
Franklin Mutual Global Discovery R6
Price$32.79
Change+$0.14 (+0.43%)
VolumeN/A
CapitalizationN/A
Lazard Equity Franchise Open Shares
Price$10.01
Change+$0.11 (+1.11%)
VolumeN/A
CapitalizationN/A
FMDRX vs LZFOX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FMDRX vs. LZFOX commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FMDRX is a StrongSell and LZFOX is a Buy.

FUNDAMENTALS
Fundamentals
FMDRX has more cash in the bank: 9.19B vs. LZFOX (182M). LZFOX pays higher dividends than FMDRX: LZFOX (2.04) vs FMDRX (1.51). FMDRX was incepted earlier than LZFOX: FMDRX (12 years) vs LZFOX (7 years). LZFOX is a more actively managed with annual turnover of: 81.00 vs. FMDRX (35.47). LZFOX has a lower initial minimum investment than FMDRX: LZFOX (2500) vs FMDRX (1000000). FMDRX annual gain was more profitable for investors over the last year : 7.71 vs. LZFOX (1.80). FMDRX return over 5 years is better than : 10.24 vs. LZFOX (0.04).
FMDRXLZFOXFMDRX / LZFOX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence12 years7 years-
Gain YTD7.5571.316574%
Front LoadN/AN/A-
Min. Initial Investment1000000250040,000%
Min. Initial Investment IRAN/AN/A-
Net Assets9.19B182M5,052%
Annual Yield % from dividends1.512.0474%
Returns for 1 year7.711.80429%
Returns for 3 years-0.45-13.673%
Returns for 5 years10.240.0423,927%
Returns for 10 years0.22N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WKSP0.640.06
+10.17%
Worksport Ltd
HOOD36.651.56
+4.45%
Robinhood Markets
NKTR1.050.04
+3.96%
Nektar Therapeutics
GEF71.301.86
+2.68%
Greif
RWT7.170.06
+0.84%
Redwood Trust